BWAY PRESS-RELEASE SEC Filing Analysis

Final — all horizons settled through T+60d

BWAY ▲ +1.96% at T+60d

LONG call ✓ call won +1.96% · α vs SPY -9.56% · entry $13.77 → $14.04

Last close $14.41 (close Jun 8) · +4.65% from $13.77 entry

Entry anchored
Mar 10, 03:59 PM ET
via Databento tick

T+1d

-0.22%

call -0.22% · α +1.27%

$13.74

settled 3mo ago

T+5d

-2.40%

call -2.40% · α -0.21%

$13.44

settled 3mo ago

T+20d

+3.85%

call +3.85% · α +3.33%

$14.30

settled 2mo ago

T+60d

+1.96%

call +1.96% · α -9.56%

$14.04

settled 5d ago

Price Chart

Loading chart...

Executive Summary

BrainsWay reported strong Q4 and full-year 2025 results with 27% YoY revenue growth to $52.2 million, net income up 161% to $7.6 million, and raised 2026 guidance projecting $66–68 million in revenue (27–30% growth) and Adjusted EBITDA of $12–14 million (86–100% growth). The company also secured FDA clearances for adolescent depression and an accelerated treatment protocol, expanding its market potential.

Key Financial Metrics

Revenue

$52.2M

+27.0% YoY

EPS

$0.20

Guidance

$66M-$68M

raised

Actionable Insight

The combination of strong top-line growth, expanding profitability, rising backlog, and new FDA clearances suggests accelerating commercial momentum. Traders should monitor execution against the aggressive 2026 EBITDA guidance and adoption of the new adolescent and SWIFT protocols as key catalysts.

Key Facts

Q4 2025 revenue: $14.5M (+27% YoY)
Full-year 2025 revenue: $52.2M (+27% YoY)
Full-year 2025 net income: $7.6M (+161% YoY)
Adjusted EBITDA for 2025: $7.0M (+55% YoY)
Remaining performance obligations up 43% to $70M
2026 revenue guidance: $66M–$68M (27–30% growth)
2026 Adjusted EBITDA guidance: $12M–$14M (86–100% growth)
FDA cleared Deep TMS for adolescents (15–21) with MDD and approved accelerated SWIFT™ protocol

Financial Impact

Revenue growth accelerating at scale with expanding margins; $18M midpoint increase in Adjusted EBITDA expected in 2026

revenuenet incomeebitdaoperating leveragecash flow

Risk Factors

Forward-looking guidance may not be achieved
High growth expectations already priced into stock (OTC market, $961M market cap)
Cash balance declined slightly despite strong net income due to working capital outflows

Market Snapshot

Exchange

OTC

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

Document	Accession Number
PRESS-RELEASE Data (Synthetic)	press-3253665

6 reports for BWAY

T+1T+5T+20T+60

100% Hit rate 4 of 4 directional calls best @ T+60▲ +27.55%Mar 4, 2026

Filters

Reports for BWAY — sortable, filterable
	Type				Now
May 18, 2026 22d ago	Press Release NEUTRAL ★ 4/10	$14.88 $15.89	▲ +6.79%	▲ +5.17%	$14.41 (−3.16%)
May 13, 2026 27d ago	Press Release BULLISH ★ 8/10	$16.31 $14.89	▼ −8.71%	▼ −7.55%	$14.41 (−11.65%)
Mar 26, 2026 10w ago	6-K BULLISH ★ 7/10	$13.49 $13.57	▲ +0.59%	▼ −1.04%	$14.41 (+6.82%)
Mar 26, 2026 10w ago	Press Release BULLISH ★ 7/10	$13.49 $13.57	▲ +0.59%	▼ −1.04%	$14.41 (+6.82%)
Mar 11, 2026 12w ago	Press Release BULLISH ★ 8/10	$13.77 $13.44	▼ −2.40%	▼ −0.21%	$14.41 (+4.65%)
Mar 4, 2026 13w ago	Press Release BULLISH ★ 8/10	$12.45 $13.77	▲ +10.60%	▲ +11.94%	$14.41 (+15.74%)

US Market Status

Market Closed — Opens in 8h 59m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access